Chronic urticaria: Pathophysiology and treatment approaches

Journal of Allergy and Clinical Immunology

Volumn 98, Issue 6 SUPPL. 2, 1996, Pages

  Tharp, Michael D ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cetirizine; Chronic disease; Corticosteroids; Drug therapy; H1 antihistamines; Urticaria

Indexed keywords

ASTEMIZOLE; CORTICOSTEROID; DOXEPIN; NIFEDIPINE; TERFENADINE;

CARDIOTOXICITY; CHRONIC URTICARIA; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATORY INFILTRATE; MAST CELL; NEUTROPHIL; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; TREATMENT PLANNING;

CHRONIC DISEASE; HUMANS; URTICARIA;

EID: 0030458525     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(96)70060-x     Document Type: Article

References (45)

1. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angio-edema: a review of 554 patients. Br J Dermatol 1969;81:588-97.
2. Tharp MD, Levine MI, Fireman P. Urticaria. In: Slavin R, Fireman P, editors. Atlas of allergies. New York: Gower Medical Publishing, 1990:16:2-15.
3. Mathews KP. Urticaria and angioedema. J Allergy Clin Immunol 1983;72:1-14.
4. Monroe EW. Urticaria. Int J Dermatol 1981;20:32-41.
5. Jones RR, Bhogal B, Dash A, Schifferli J. Urticaria and vasculitis: a continuum of histological and immunopathological changes. Br J Dermatol 1983;108:695-703.
6. Volonakis M, Katsarou-Katsari A, Stratigos J. Etiologic factors in childhood chronic urticaria. Ann Allergy 1992;69:61-5.
7. Schwartz L, Huff T. Biology of mast cells and basophils. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy principles and practice. St. Louis: Mosby-Year Book, 1993:135-68.
8. Kaplan AP, Horakova Z, Katz SI. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978;61:350-4.
9. Phanuphak P, Schocket AL, Arroyave CM, Kohler PF. Skin histamine in chronic urticaria. J Allergy Clin Immunol 1980;65:371-5.
10. 4) in human skin. J Invest Dermatol 1983;80:115-9.
11. Frew AJ, Kay AB. The pattern of human late-phase skin reactions to extracts of aeroallergens. J Allergy Clin Immunol 1988;81:1117-21.
12. Solley GO, Gleich GJ, Jordon RE, Schroeter AL. The late phase of the immediate wheal and flare skin reaction: its dependence upon IgE antibodies. J Clin Invest 1976;58:408-20.
13. Frew AJ, Kay AB. Eosinophils and T-lymphocytes in late-phase allergic reactions. J Allergy Clin lmmunol 1990;85:533-9.
14. Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-604.
15. Grattan CE, Boon AP, Eady RAJ, Winkelmann RK. The pathology of the autologous serum skin test response in chronic urticaria resembles IgE-mediated late-phase reactions. Int Arch Allergy Appl Immunol 1990;93:198-204.
16. Grant JA, Alam R, Lett-Brown MA. Histamine-releasing factors and inhibitors: historical perspectives and possible implications in human illness. J Allergy Clin Immunol 1991;88:683-93.
17. White MV, Baer H, Kubota Y, Kaliner M. Neutrophits and mast cells. Characterization of cells responsive to neutrophil-derived histamine-releasing activity (HRA-N). J Allergy Clin Immunol 1989;84:773-80.
18. O'Donnell MC, Ackerman S J, Gleich G J, Thomas LL. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983;157:1981-91.
19. Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in the human skin: an immunocytochemical and immunochemical study on normal skin and blister fluid from inflamed skin. Acta Derm Venereol 1987;67:185-92.
20. Foreman JC. Neuropeptides and the pathogenesis of allergy. Allergy 1987;42:1-11.
21. Fuller RW, Conradson TB, Dixon CM, Crossman DC, Barnes PJ. Sensory neuropeptide effects in human skin. Br J Pharmacol 1987;92:781-8.
22. Lehach JG, Rosenstreich DL. Clinical aspects of chronic urticaria. Clin Rev Allergy 1992;10:281-301.
23. Tharp MD, Kagey-Sabotka A, Marone G, Lichtenstein LM, Sullivan TJ. Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol 1987;79:646-53.
24. Cohen RW, Rosenstreich DL. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol 1986;77:802-7.
25. Callen JP, Kalbfleisch S. Urticarial vasculitis: a report of nine cases and review of the literature. Br J Dermatol 1982;107:87-93.
26. Werni R, Schwarz T, Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica 1986;172:36-40.
27. Andri L, Senna G, Betteli C, Givanni S, Andri G, Lombardi C. A comparison of the efficacy of cetirizine and terfenadine: a double-blind, controlled study of chronic idiopathic urticaria. Allergy 1993;48:358-65.
28. Monroe EW, Bernstein DI, Fox RW, Grabiec SV, Honsinger RW, Kalivas JT, et al. Relative efficacy and safety of loratadine, hydroxyzine, an d placebo in chronic idiopathic urticaria. ArzneimittelForschung 1992;42:1119-21.
29. Cerio R, Lessof MH. Treatment of chronic idiopathic urticaria with terfenadine. Clin Allergy 1984;14:139-41.
30. Woodward JK. Pharmacology and toxicology of nonclassical antihistamines. Cutis 1988;42:5-9.
31. Smith SJ. Cardiovascular toxicity of antihistamines. Otolaryngol Head Neck Surg 1994;111:348-54.
32. Rao KA, Adlakha A, Verma-Ansil B, Meloy TD, Stanton MS. Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc 1994;69:589-93.
33. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90.
34. Harto A, Sendagorta E, Ledo A. Doxepin in the treatment of chronic urticaria. Dermatologica 1985;170:90-3.
35. Thomas RH, Browne PD, Kirby JD. The influence of ranitidine, alone and in comination with clemastine on histamine-mediated cutaneous wheal and flare reactions in human skin. Br J Clin Pharmacol 1985;20:377-82.
36. Kaliner M, Shelhamer JH, Ottesen EA. Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 1982;69:283-9.
37. 2 antihistamine therapy in chronic urticaria. Arch Dermatol 1981;117:404-7.
38. Juhlin D, Landor M. Drug therapy for chronic urticaria. Clin Rev Allergy 1992;10:349-69.
39. Bressler RB, Sowell K, Huston DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blind, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989;83:756-63.
40. Schleimer R. Glucocorticosteroids. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, editors. Allergy principles and practice. St. Louis: Mosby-Year Book, 1993:893-925.
41. 1-receptor antagonist treatment. J Allergy Clin Immunol 1990;86:995-9.
42. 1 receptor blockade on the early and late response to cutaneous antigen challenge. J Pharmacol Exp Ther 1992;262:964-70.
43. Zavadak D, Tharp MD. Chronic urticaria as a manifestation of the late phase reaction. Immunol Allergy Clin North Am 1995;15:745-59.
44. Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe unremitting, chronic urticaria. Lancet 1992;339:1078-80.
45. Fradin MS, Ellis CN, Goldfarb MT, Voorhees JJ. Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991;25:1065-7.